MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
2.950
+0.330 (12.60%)
At close: Jan 27, 2026, 4:00 PM EST
3.060
+0.110 (3.73%)
After-hours: Jan 27, 2026, 8:00 PM EST
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $112.88 million as of January 27, 2026. Its market cap has increased by 102.61% in one year.
Market Cap
112.88M
Enterprise Value
101.80M
1-Year Change
102.61%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $112.88M, an increase of 120.91%. That is a compound annual growth rate of 25.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 100.26M | 71.24% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 103.13M |
| Agenus | 102.71M |
| Korro Bio | 101.05M |
| MindWalk Holdings | 100.85M |
| Vivani Medical | 100.67M |
| Pyxis Oncology | 100.25M |
| Dogwood Therapeutics | 99.13M |
| eXoZymes | 98.28M |